Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib
Author:
Affiliation:
1. Dermatology Unit Department of Mentals and Physical Health and Preventive medicine University of Campania Luigi Vanvitelli Naples Italy
2. Department of Anesthesiology, Surgery and Emergency University of Campania Luigi Vanvitelli Naples Italy
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17705
Reference8 articles.
1. Overview of atopic dermatitis;Avena‐Woods C;Am J Manag Care,2017
2. Atopic dermatitis: diagnosis and treatment;Frazier W;Am Fam Physician,2020
3. Atopic Dermatitis: Pathophysiology
4. Dupilumab for treatment of atopic dermatitis
5. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dupilumab‐associated head and neck dermatitis: Rapid response with abrocitinib treatment;Skin Health and Disease;2023-12-13
2. Real‐world experience of baricitinib in atopic dermatitis: including add‐on therapy for patients using dupilumab;International Journal of Dermatology;2023-12-06
3. Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study;Journal of the American Academy of Dermatology;2023-12
4. Atopic Dermatitis and Difficult-to-Treat Areas: A Case Series of Four Patients With Dupilumab-Resistant Primary Atopic Blepharitis and Successfully Treated With Upadacitinib;Dermatitis®;2023-11-01
5. Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up);Journal of the American Academy of Dermatology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3